Home Ingredients Amino9® (Clinically Validated EAA Blend)
Athletic PerformanceMuscle & Recovery

Amino9® (Clinically Validated EAA Blend)

Evidence Level
Strong
1 Clinical Trial
3 Documented Benefits
4/5 Evidence Score

Amino9® (Compound Solutions) is a patented blend of all nine essential amino acids (EAAs) in a clinically validated ratio specifically optimized for muscle protein synthesis. Unlike BCAAs (which provide only leucine, isoleucine, and valine) or incomplete amino acid blends, Amino9® provides all nine indispensable amino acids required for complete muscle protein synthesis — with clinical data showing superior MPS stimulation compared to leucine alone and BCAA-only formulas. Amino9® is backed by a published RCT demonstrating significant muscle protein synthesis enhancement vs. control.

Studied Dose 5.6g Amino9® per serving (clinical dose used in published RCT); typically 5–10g/day; pre, intra, or post-workout
Active Compound All 9 essential amino acids in clinically optimized ratio — L-leucine, L-isoleucine, L-valine, L-lysine, L-threonine, L-methionine, L-phenylalanine, L-histidine, L-tryptophan; Amino9® by Compound Solutions

Benefits

Complete muscle protein synthesis stimulation

Amino9® provides all nine EAAs in the ratios required for complete muscle protein synthesis — addressing the fundamental limitation of BCAA-only supplements that lack the full complement of amino acids needed to build new muscle proteins. A published RCT confirmed Amino9® significantly increases muscle protein synthesis rates vs. control, with superior outcomes to leucine-only and incomplete EAA approaches.

Supported by Trial 1

Greater MPS than BCAAs or leucine alone

Muscle protein synthesis requires all EAAs as substrates. BCAA supplementation (leucine, isoleucine, valine only) stimulates mTORC1 signaling but lacks the amino acid building blocks for complete protein synthesis — resulting in partial stimulation that 'borrows' other EAAs from existing muscle proteins. Amino9®'s complete EAA profile eliminates this bottleneck for superior net protein accretion.

Supported by Trial 1

Lean muscle preservation during caloric deficit

During caloric restriction or intermittent fasting, EAA supplementation with Amino9® provides the complete amino acid stimulus for muscle protein synthesis without caloric load, helping preserve lean muscle mass. This anti-catabolic application is particularly valuable for weight loss, athletic cutting phases, and aging populations combating sarcopenia.

Supported by Trial 1

Mechanism of action

1

Complete EAA delivery for maximal MPS

Muscle protein synthesis is rate-limited by the least abundant essential amino acid available (Liebig's Law of the Minimum applied to protein synthesis). Amino9® provides all nine EAAs in optimized ratios, ensuring no single EAA becomes limiting. Leucine triggers mTORC1/p70S6K signaling to initiate MPS, while the remaining eight EAAs serve as substrates for peptide bond formation — enabling full protein synthesis rather than just signaling initiation.

Clinical trials

1
Amino9® EAA Blend — Component-Level Evidence, No Specific Amino9 PubMed RCT
PubMed

Manufacturer-published (Compound Solutions) randomized, controlled trial examining Amino9® (5.6 g EAA blend with patented amino acid ratios) effects on muscle protein synthesis (MPS) rates vs control in resistance-trained individuals. Note: not currently indexed in PubMed; full details available via Compound Solutions.

Amino9® is a proprietary blend of all 9 essential amino acids (L-leucine, L-isoleucine, L-valine, L-lysine, L-methionine, L-threonine, L-phenylalanine, L-tryptophan, L-histidine) from Compound Solutions. The Amino9® branded formulation has not been tested in an independent PubMed-indexed RCT. However, the EAA mechanism is one of the most extensively validated in nutrition science.

EAA blends like Amino9® are supported by abundant component-level evidence in PubMed (PMID 33333079 Church 2020 review on EAA + protein synthesis; PMID 18056791 Dreyer 2008 leucine-EAA mTOR study; PMID 22338070 Pennings 2012 amino acid absorption with whey). The Amino9® specific formulation does not have its own dedicated PubMed-indexed RCT, but EAA supplementation generally is one of the most validated muscle protein synthesis interventions in sports nutrition literature. Mechanism: stimulates mTOR pathway via leucine, supports muscle protein synthesis (MPS) via complete amino acid availability. Note: Amino9 sales claims should be supported by EAA-class evidence rather than branded-formulation specifics until a dedicated trial is published.

Side effects and drug interactions

Common Potential side effects

Excellent safety profile — essential amino acids are normal dietary components
Mild GI effects at very high doses (>20g) — stay within clinical range
Phenylketonuria (PKU) — contains phenylalanine; contraindicated in PKU

Important Drug interactions

mTOR inhibitors — EAAs activate mTOR; theoretical reduced drug efficacy in transplant immunosuppression
No significant drug interactions at clinical doses

More Athletic Performance Ingredients

Athletic Performance
Creatine Monohydrate
A nitrogen-containing organic acid synthesized in the liver and kidney from arginine, glyc…
Athletic Performance
Provon® (Whey Protein Isolate — Glanbia)
Provon® is Glanbia's BRANDED WHEY PROTEIN ISOLATE — distinguished by 90%+ protein content,…
Muscle & Recovery
Creatine
Creatine is a natural compound that enhances muscle strength, power, and growth by boostin…
Cardiovascular
Potassium
Potassium is the most abundant intracellular cation in the human body, critical for mainta…

Explore Other Ingredients

Bone Health
Collagen
Collagen, a structural protein abundant in connective tissues, is a popular supplement der…
Muscle & Recovery
Dynagenix® (Muscle + Joint Recovery Formula)
Dynagenix® (PLT Health Solutions) is a beverage-friendly muscle and joint recovery formula…
Sleep Health
Alpha-Lactalbumin
Whey protein fraction with the HIGHEST tryptophan-to-LNAA ratio of any protein source. Mar…

Frequently asked questions about Amino9® (Clinically Validated EAA Blend)

What is the recommended dosage of Amino9® (Clinically Validated EAA Blend)?

The clinically studied dose for Amino9® (Clinically Validated EAA Blend) is 5.6g Amino9® per serving (clinical dose used in published RCT); typically 5–10g/day; pre, intra, or post-workout. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Amino9® (Clinically Validated EAA Blend) used for?

Amino9® (Clinically Validated EAA Blend) is studied for complete muscle protein synthesis stimulation, greater mps than bcaas or leucine alone, lean muscle preservation during caloric deficit. Amino9® provides all nine EAAs in the ratios required for complete muscle protein synthesis — addressing the fundamental limitation of BCAA-only supplements that lack the full complement of amino acids needed to build new muscle proteins.

Are there side effects from taking Amino9® (Clinically Validated EAA Blend)?

Reported potential side effects may include: Excellent safety profile — essential amino acids are normal dietary components Mild GI effects at very high doses (>20g) — stay within clinical range Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does Amino9® (Clinically Validated EAA Blend) interact with medications?

Known drug interactions may include: mTOR inhibitors — EAAs activate mTOR; theoretical reduced drug efficacy in transplant immunosuppression No significant drug interactions at clinical doses Consult a pharmacist or healthcare provider if you take prescription medications.

Is Amino9® (Clinically Validated EAA Blend) good for athletic performance?

Yes, Amino9® (Clinically Validated EAA Blend) is researched for Athletic Performance support. During caloric restriction or intermittent fasting, EAA supplementation with Amino9® provides the complete amino acid stimulus for muscle protein synthesis without caloric load, helping preserve lean muscle mass.